IN2014MN02090A - - Google Patents
Info
- Publication number
- IN2014MN02090A IN2014MN02090A IN2090MUN2014A IN2014MN02090A IN 2014MN02090 A IN2014MN02090 A IN 2014MN02090A IN 2090MUN2014 A IN2090MUN2014 A IN 2090MUN2014A IN 2014MN02090 A IN2014MN02090 A IN 2014MN02090A
- Authority
- IN
- India
- Prior art keywords
- brain
- medicine
- anesthetic
- alleviate
- prevent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012125535 | 2012-05-31 | ||
| PCT/JP2013/065094 WO2013180240A1 (ja) | 2012-05-31 | 2013-05-30 | 全身麻酔薬と、水素とを組み合わせてなる、医薬 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN02090A true IN2014MN02090A (enExample) | 2015-09-04 |
Family
ID=49673427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2090MUN2014 IN2014MN02090A (enExample) | 2012-05-31 | 2013-05-30 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20150079197A1 (enExample) |
| EP (1) | EP2857026A4 (enExample) |
| JP (1) | JP6168420B2 (enExample) |
| KR (1) | KR20150018832A (enExample) |
| CN (1) | CN104394873A (enExample) |
| AU (1) | AU2013268366A1 (enExample) |
| BR (1) | BR112014029260A2 (enExample) |
| CA (1) | CA2874579A1 (enExample) |
| HK (1) | HK1205450A1 (enExample) |
| IL (1) | IL235718A0 (enExample) |
| IN (1) | IN2014MN02090A (enExample) |
| MX (1) | MX2014014543A (enExample) |
| NZ (1) | NZ701553A (enExample) |
| RU (1) | RU2014152690A (enExample) |
| SG (1) | SG11201407489TA (enExample) |
| WO (1) | WO2013180240A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6253029B2 (ja) * | 2015-01-21 | 2017-12-27 | 大陽日酸株式会社 | 麻酔器用取付キット |
| US20180338995A1 (en) * | 2017-05-23 | 2018-11-29 | Perricone Hydrogen Water Company, Llc | Systems and methods for treatments using hydrogen and/or noble gases |
| US11129848B2 (en) * | 2017-08-08 | 2021-09-28 | Perricone Hydrogen Water Company, Llc | Medication enhancement using hydrogen |
| US20210222174A1 (en) * | 2018-06-29 | 2021-07-22 | John Mansell | Compositions and methods for the treatment of anesthesia-induced neurotoxicity |
| US11123365B2 (en) | 2019-11-18 | 2021-09-21 | Perricone Hydrogen Water Company, Llc | Compositions comprising palmitoylethanolamide and hydrogen water, and methods thereof |
| JP7019910B2 (ja) * | 2020-07-21 | 2022-02-16 | ＭｉＺ株式会社 | 薬の副作用、薬の副作用に関連する症状、および／または、治療に伴う副作用を予防および／または改善するための組成物 |
| CN117861037A (zh) * | 2022-10-11 | 2024-04-12 | 上海氢医医疗科技有限公司 | 氢气吸入治疗自闭症 |
| CN119303200A (zh) * | 2024-12-17 | 2025-01-14 | 山东百多安医疗器械股份有限公司 | 一种可以释放氢气减少神经损伤的麻醉机 |
-
2013
- 2013-05-30 MX MX2014014543A patent/MX2014014543A/es unknown
- 2013-05-30 WO PCT/JP2013/065094 patent/WO2013180240A1/ja not_active Ceased
- 2013-05-30 CN CN201380028933.5A patent/CN104394873A/zh active Pending
- 2013-05-30 AU AU2013268366A patent/AU2013268366A1/en not_active Abandoned
- 2013-05-30 NZ NZ701553A patent/NZ701553A/en not_active IP Right Cessation
- 2013-05-30 US US14/397,229 patent/US20150079197A1/en not_active Abandoned
- 2013-05-30 JP JP2014518736A patent/JP6168420B2/ja not_active Expired - Fee Related
- 2013-05-30 BR BR112014029260A patent/BR112014029260A2/pt not_active Application Discontinuation
- 2013-05-30 KR KR20147035945A patent/KR20150018832A/ko not_active Withdrawn
- 2013-05-30 CA CA2874579A patent/CA2874579A1/en not_active Abandoned
- 2013-05-30 RU RU2014152690A patent/RU2014152690A/ru unknown
- 2013-05-30 IN IN2090MUN2014 patent/IN2014MN02090A/en unknown
- 2013-05-30 HK HK15103729.5A patent/HK1205450A1/en unknown
- 2013-05-30 EP EP13796554.7A patent/EP2857026A4/en not_active Withdrawn
- 2013-05-30 SG SG11201407489TA patent/SG11201407489TA/en unknown
-
2014
- 2014-11-16 IL IL235718A patent/IL235718A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20150018832A (ko) | 2015-02-24 |
| CA2874579A1 (en) | 2013-12-05 |
| WO2013180240A1 (ja) | 2013-12-05 |
| EP2857026A4 (en) | 2015-11-04 |
| US20150079197A1 (en) | 2015-03-19 |
| BR112014029260A2 (pt) | 2017-06-27 |
| JP6168420B2 (ja) | 2017-07-26 |
| SG11201407489TA (en) | 2014-12-30 |
| MX2014014543A (es) | 2015-06-05 |
| NZ701553A (en) | 2016-06-24 |
| RU2014152690A (ru) | 2016-07-20 |
| IL235718A0 (en) | 2015-01-29 |
| EP2857026A1 (en) | 2015-04-08 |
| AU2013268366A1 (en) | 2015-03-19 |
| JPWO2013180240A1 (ja) | 2016-01-21 |
| HK1205450A1 (en) | 2015-12-18 |
| CN104394873A (zh) | 2015-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN02090A (enExample) | ||
| MX371344B (es) | Antagonistas de il-4r para usarse en el tratamiento o prevención de asma persistente y asma severa. | |
| EA201991484A1 (ru) | Лекарственные формы энзалутамида | |
| PH12014501997A1 (en) | Esketamine for the treatment of treatment-refractory or treatment-resistant depression | |
| IN2015DN03029A (enExample) | ||
| AU349827S (en) | Respirator mask | |
| IN2015DN03219A (enExample) | ||
| MX356728B (es) | Combinación farmacéutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2. | |
| PH12015501071A1 (en) | Combination therapy of anti-her3 antibodies | |
| UY34961A (es) | Nanocarbono que contiene caucho natural | |
| NZ705008A (en) | Novel modulators and methods of use | |
| EA201591679A1 (ru) | Способ нетоксического лечения абстиненции, вызванной лекарственным средством | |
| PH12016501965A1 (en) | S1p modulator immediate release dosage regimen | |
| AU352986S (en) | Nasal dilation device | |
| NZ702242A (en) | Agent for prophylactic and/or therapeutic treatment of peripheral neuropathic pain caused by anticancer agent | |
| IN2015DN00515A (enExample) | ||
| MX2016007947A (es) | Uso de un antagonista de receptores de opioides con actividad kappa y vortioxetina para el tratamiento de trastorno depresivo con caracteristicas melancolicas. | |
| SI2874600T1 (sl) | Farmacevtski sestavek za zdravljenje hripavosti ali bolečin v grlu | |
| BR112015005268A2 (pt) | seringa contendo uma composição, em particular farmacêutica, composta por imunoglobulinas, seu método de fabricação e respectivo uso | |
| ECSP12012126A (es) | Medicamento | |
| MX2015013755A (es) | Formulacion farmaceutica para uso en el tratamiento y/o prevencion de restenosis. | |
| PH12017500923A1 (en) | New dosage and use of a a2a antagonist | |
| MX2015008454A (es) | Uso de pregn-4-en-20-in-3-ona para el tratamiento de trastornos depresivos. | |
| MX2014012535A (es) | Terapia de combinacion de anticuerpos anti-mif y quimioterapeuticos. | |
| MX365192B (es) | Derivados de bendamustina y compuestos relacionados, y uso medico de los mismos para la terapia de cancer. |